TrialMalaria journal2021

Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa.

Gilles Ndayisaba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.